Abdallah Marey Aboshhran et al. 2023. PUBLIC INTEREST IN THE OFF-LABEL USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (OZEMPIC) FOR COSMETIC WEIGHT LOSS‏. Journal of Population Therapeutics and Clinical Pharmacology. 30, 2 (Feb. 2023), 745–747. DOI:https://doi.org/10.53555/jptcp.v30i2.4746.